Declaration of interest and financial disclosures
The author is an inventor on issued patents pertaining to the active metabolite of ibogaine. She is a founder and shareholder in a Florida corporation, DemeRx, Inc., which is advancing clinical trials of noribogaine for opioid detoxification and maintenance therapy, among other indications. The author conducted offshore ibogaine research studies with government approval in St. Kitts, West Indies.